Metraipolis › archive › dc_1eb16ffb6d76

The future of AI regulation in drug development: a comparative analysis — Europe PMC PMID:41221487

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41221487
DOI
10.1093/jlb/lsaf028
License (as archived)
solo-consultazione
Archived
2026-10-06T09:15:49.989Z
SHA-256 of the archived text
b15f4a47f7721fb52907f297575c393107153d4bc8215c6073583f2af18783a2
Stable URL of this page
https://metraipolis.com/documento/dc_1eb16ffb6d76

How to cite

The future of AI regulation in drug development: a comparative analysis — Europe PMC PMID:41221487 — Europe PMC (en), https://europepmc.org/article/MED/41221487 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1eb16ffb6d76 (Metraipolis archive dc_1eb16ffb6d76, sha256 b15f4a47f7721fb52907f297575c393107153d4bc8215c6073583f2af18783a2)
BibTeX
@misc{dc1eb16ffb6d76,
  title = {The future of AI regulation in drug development: a comparative analysis — Europe PMC PMID:41221487},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41221487},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1eb16ffb6d76; sha256 b15f4a47f7721fb52907f297575c393107153d4bc8215c6073583f2af18783a2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41221487. Agents can read the archived copy with the MCP tool read_document.